1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Motherisk Nausea and Vomiting of Pregnancy (NVP) ForumMotherisk receives questions from around the world about morning sickness symptoms, effects, treatments and ways to cope. Those questions and answers are posted here for anyone to read, provided the reader acknowledges and accepts the proviso and disclaimer below.
What are the risks of stemetil during the 13-14wk? I have found info. of possible adverse effects such as lethargy or paradoxical hperexcitability, tremor and low apgar score. My question is are these risks only if the drugs are taken close to delivery or maybe becasue of prolonged use? and if these possible adverse effects really happen, are they a permanent or a temporary situation?
Stemetil (prochlorperazine) is part of the phenothiazine group of medications. They are known not to be teratogenic (do not cause birth defects). For more detailed information about Stemetil's possible effects on the baby, based on duration of intake or timing of use during pregnancy, please speak to your doctor, pharmacist or a teratogen counselor. Motherisk counselors are available Monday through Friday, 9 a.m. to 5 p.m. EST by calling (416) 813-6780. Or visit OTIS to find a teratogen information service in your area.